While tumor suppression by PPARα has been reported in some cancers including melanoma [8] and glioblastoma [9], PPARα has also been found to lead to progression of tumor growth in other cancers including hepatocellular carcinoma [10] and breast cancer [11]. Here, PPARA is linked to breast carcinoma.